The Educated Patient Podcast

15: New Cholesterol Guidelines Emphasize Personalized Cardiovascular Risk

39 min · 2 de jun de 2026
Portada del episodio 15: New Cholesterol Guidelines Emphasize Personalized Cardiovascular Risk

Descripción

For decades, cholesterol management has largely focused on identifying problems and treating patients after cardiovascular disease has already developed. But according to Michael D. Shapiro, D.O., the inaugural Fred M. Parrish professor of cardiology and molecular medicine at Wake Forest University and a contributor to the new American Heart Association’s 2026 cholesterol guidelines, that approach is changing. The latest recommendations reflect a growing shift toward prevention, with a stronger emphasis on identifying risk factors earlier in life and tailoring treatment plans to individual patients. Advances in genetics, imaging and blood testing have helped researchers better understand who may be at risk for heart disease long before symptoms appear.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de The Educated Patient Podcast!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos

Todos los episodios

16 episodios

episode 15: New Cholesterol Guidelines Emphasize Personalized Cardiovascular Risk artwork

15: New Cholesterol Guidelines Emphasize Personalized Cardiovascular Risk

For decades, cholesterol management has largely focused on identifying problems and treating patients after cardiovascular disease has already developed. But according to Michael D. Shapiro, D.O., the inaugural Fred M. Parrish professor of cardiology and molecular medicine at Wake Forest University and a contributor to the new American Heart Association’s 2026 cholesterol guidelines, that approach is changing. The latest recommendations reflect a growing shift toward prevention, with a stronger emphasis on identifying risk factors earlier in life and tailoring treatment plans to individual patients. Advances in genetics, imaging and blood testing have helped researchers better understand who may be at risk for heart disease long before symptoms appear.

2 de jun de 202639 min